Gabapentin NDC 63187-785

NDC codes

FDA NDC Directory

Product NDC (as listed)63187-785Labeler and product segments. Claims need a package NDC.

Product NDC at billing width63187-0785Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
63187-785-00	63187078500	100 TABLET in 1 BOTTLE (63187-785-00)Marketed from Dec 1, 2016
63187-785-30	63187078530	30 TABLET in 1 BOTTLE (63187-785-30)Marketed from Dec 1, 2016
63187-785-60	63187078560	60 TABLET in 1 BOTTLE (63187-785-60)Marketed from Dec 1, 2016
63187-785-72	63187078572	120 TABLET in 1 BOTTLE (63187-785-72)Marketed from Dec 1, 2016
63187-785-90	63187078590	90 TABLET in 1 BOTTLE (63187-785-90)Marketed from Dec 1, 2016

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Gabapentin
Generic name (nonproprietary): gabapentin
Active ingredients: Gabapentin — 600 mg/1
Dosage form: Tablet
Route: Oral
Labeler: Proficient Rx LP
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 202764
Marketing start: Jul 22, 2016
Listing expires: Dec 31, 2026
Other FDA classes: Decreased Central Nervous System Disorganized Electrical Activity (Physiologic effect)
Identifiers: Product ID 63187-785_1f31e7f3-c013-4492-90ac-481c23448403SPL ID 1f31e7f3-c013-4492-90ac-481c23448403SPL set ID f6baeb5c-ca9c-4730-aeb8-8f8732e8ca3aRxCUI 310433UNII 6CW7F3G59X
Pharmacologic class: Anti-epileptic Agent

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N463187078500 followed by a unit qualifier and the quantity

Package 63187-0785-00. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jan 1, 2021.

Indications (excerpt from the label)

Gabapentin is indicated for: • Postherpetic neuralgia in adults ( 1 ) • Adjunctive therapy in the treatment of partial onset seizures, with and without secondary generalization, in adults and pediatric patients 3 years and older with epilepsy ( 1 ) Gabapentin Tablets, USP is indicated for: • Management of postherpetic neuralgia in adults • Adjunctive therapy in the treatment of partial onset seizures, with and without secondary generalization, in adults and pediatric patients 3 years and older with epilepsy

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 202764

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 202764
Product	Strength	Form · route	Labeler	Product NDC
Gabapentin	Gabapentin 800 mg/1	TabletOral	Cipla USA Inc.	69097-811
Gabapentin	Gabapentin 600 mg/1	Tablet, Film coatedOral	Exelan Pharmaceuticals Inc.	76282-405
Gabapentin	Gabapentin 600 mg/1	TabletOral	Cipla USA Inc.	69097-812
Gabapentin	Gabapentin 800 mg/1	Tablet, Film coatedOral	Exelan Pharmaceuticals Inc.	76282-406